Molecular basis of rifampin resistance in Mycobacterium leprae.
Rifampin is currently the most potent drug used in leprosy control programs. We show that the rifampin resistance which emerged in nine patients with lepromatous leprosy, who had received rifampin monotherapy, stemmed from mutations in the rpoB gene, which encodes the beta subunit of RNA polymerase...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1993
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC187686/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8460911/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.3.414 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|